With over 25 years of international experience in biotechnology, healthcare and financial services as an executive and corporate lawyer, Tanya Zharov brings a strong track record in business and innovation-driven global life science to Alvotech. A lawyer by training, as General Counsel Tanya is responsible for all legal affairs of the company, compliance and security and serves as Board Secretary.
Prior to joining Alvotech in 2020, from 2016 she was the Deputy CEO and Compliance Officer of deCODE genetics, a renowned Icelandic biotech and world leader in human genetics, that was acquired by Amgen in 2012. She was also deCODE’s Corporate Counsel from 1999 to 2007. In this capacity she led the securities regulation and compliance team behind deCODE’s US IPO in 2000, the first time that shares of an Icelandic company were admitted to trading on a US stock exchange.
In-between her stints at deCODE genetics, from 2008 to 2015 Tanya was a Founding Partner and Deputy CEO of Audur Capital, an Icelandic securities firm. Her responsibilities included legal affairs, wealth management, corporate finance, private equity, and capital markets. Tanya is a specialist in US and global public markets law, regulation, and best practices. Early in her career, she served as a Tax Partner at PricewaterhouseCoopers. She holds a Cand. Juris law degree from the University of Iceland and is a European Patent Attorney.